Article
Adjuvanting Coxevac® with QuilA® skews Coxiella burnetii-induced inflammatory responses towards a sustained Th1-CD8+-mediated activation and increases protection in an experimental goat model
2022-08-19
Abstract excerpt
<title>Abstract</title> <p>Coxevac® is the EMA-approved veterinary vaccine for the protection of cattle and goats against Q Fever, a zoonotic bacterial disease due to Coxiella burnetii. Since Coxevac® reduces bacterial shedding and clinical symptoms but does not prevent infection, novel, ready-to-use vaccine formulations are needed to increase its immunogenicity. Here, a goat vaccination-challenge model was used...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a2df70a4-1169-50bb-bd79-991b29be94b7
- DOI
- 10.21203/rs.3.rs-1897579/v1
